|
| 36572991 | CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. | Cancer | 2023 |
| 38057616 | Deep learning-based segmentation of multisite disease in ovarian cancer. | Eur Radiol Exp | 2023 |
| 37678887 | Trends in Uterine Cancer Mortality in the United States: A 50-Year Population-Based Analysis. | Obstet Gynecol | 2023 |
| 37923835 | In situ profiling reveals metabolic alterations in the tumor microenvironment of ovarian cancer after chemotherapy. | NPJ Precis Oncol | 2023 |
| 37639904 | Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatment. | Gynecol Oncol | 2023 |
| 37067801 | Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine Cancer. | JAMA Netw Open | 2023 |
| 35169605 | Increasing incidence of uterine carcinosarcoma: A United States Cancer Statistics study. | Gynecol Oncol Rep | 2022 |
| 35624045 | Conditional estimates for uterine serous cancer: Tools for survivorship counseling and planning. | Gynecol Oncol | 2022 |
| 36195845 | Proteomic alterations associated with residual disease in neoadjuvant chemotherapy treated ovarian cancer tissues. | Clin Proteomics | 2022 |
| 36077609 | Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study. | Cancers (Basel) | 2022 |
| 31148502 | Incarcerated Women's Experiences of Staff-Perpetrated Rape: Racial Disparities and Justice Gaps in Institutional Responses. | J Interpers Violence | 2021 |
| 33706355 | Racial-Ethnic Comparison of Guideline-Adherent Gynecologic Cancer Care in an Equal-Access System. | Obstet Gynecol | 2021 |
| 33563487 | Clinical significance of homologous recombination deficiency score testing in endometrial Cancer. | Gynecol Oncol | 2021 |
| 33665831 | A prognostic system for epithelial ovarian carcinomas using machine learning. | Acta Obstet Gynecol Scand | 2021 |
| 33931688 | Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patients. | Sci Rep | 2021 |
| 33722415 | Racial disparities in high-risk uterine cancer histologic subtypes: A United States Cancer Statistics study. | Gynecol Oncol | 2021 |
| 35036865 | Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry. | iScience | 2021 |
| 34538531 | Obesity and altered angiogenic-related gene expression in endometrial cancer. | Gynecol Oncol | 2021 |
| 34325938 | Racial disparities in survival among women with endometrial cancer in an equal access system. | Gynecol Oncol | 2021 |
| 34170756 | "He Acted as If He Owned Me": An Exploratory Case Study Analysis of Correctional Staff Sexual Misconduct Against Women on Parole. | Violence Against Women | 2021 |
| 34278265 | Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens. | iScience | 2021 |
| 33310882 | Age and racial differences in the presentation of gestational trophoblastic neoplasia. | Int J Gynecol Cancer | 2021 |
| 32445133 | Sexting: What's Law Got to Do with It? | Arch Sex Behav | 2021 |
| 32253542 | Integration of proteomics with CT-based qualitative and radiomic features in high-grade serous ovarian cancer patients: an exploratory analysis. | Eur Radiol | 2020 |
| 32029291 | Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival. | Gynecol Oncol | 2020 |
| 31808620 | Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers. | Cancer Med | 2020 |
| 31954540 | Survival disparities in vulvar cancer patients in Commission on Cancer®-accredited facilities. | Gynecol Oncol | 2020 |
| 31954536 | Impact of adjuvant treatment and prognostic factors in stage I uterine leiomyosarcoma patients treated in Commission on Cancer®-accredited facilities. | Gynecol Oncol | 2020 |
| 31711656 | Genomic heterogeneity in peritoneal implants: A differential analysis of gene expression using nanostring Human Cancer Reference panel identifies a malignant signature. | Gynecol Oncol | 2020 |
| 32006127 | Predictors and Outcomes of Surgery in Peritoneal Mesothelioma: an Analysis of 2000 Patients from the National Cancer Database. | Ann Surg Oncol | 2020 |
| 33078591 | Uterine clear cell carcinoma risk in White versus non-White US subpopulations: does race matter? | J Gynecol Oncol | 2020 |
| 32828578 | Long term survival outcomes of stage I mucinous ovarian cancer - A clinical calculator predictive of chemotherapy benefit. | Gynecol Oncol | 2020 |
| 32753561 | Trends and survival outcomes of robotic, laparoscopic, and open surgery for stage II uterine cancer. | Int J Gynecol Cancer | 2020 |
| 32244545 | Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovarian and Endometrial Cancer Cells In Vitro. | Biomedicines | 2020 |
| 32173047 | Minority participation in phase 1 gynecologic oncology clinical trials: Three decades of inequity. | Gynecol Oncol | 2020 |
| 30827726 | GOG 8020/210: Risk stratification of lymph node metastasis, disease progression and survival using single nucleotide polymorphisms in endometrial cancer: An NRG oncology/gynecologic oncology group study. | Gynecol Oncol | 2019 |
| 35116885 | TGF-β signaling proteins and CYP24A1 may serve as surrogate markers for progesterone calcitriol treatment in ovarian and endometrial cancers of different histological types. | Transl Cancer Res | 2019 |
| 31517012 | Sixteen year-old with leiomyosarcoma in a prior benign myomectomy site. | Gynecol Oncol Rep | 2019 |
| 31454432 | Patient preferences for attributes of primary surgical debulking versus neoadjuvant chemotherapy for treatment of newly diagnosed ovarian cancer. | Cancer | 2019 |
| 31279844 | Biomarker panel for early detection of endometrial cancer in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial. | Am J Obstet Gynecol | 2019 |
| 31274231 | Final analysis of a phase I/IIa trial of the folate-binding protein-derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients. | Cancer Med | 2019 |
| 30838639 | From Discovery to Practice and Survivorship: Building a National Real-World Data Learning Healthcare Framework for Military and Veteran Cancer Patients. | Clin Pharmacol Ther | 2019 |
| 28800945 | Impact of age at diagnosis on racial disparities in endometrial cancer patients. | Gynecol Oncol | 2018 |
| 29605044 | Racial disparities in molecular subtypes of endometrial cancer. | Gynecol Oncol | 2018 |
| 29232272 | Relative Effects of Age, Race, and Stage on Mortality in Gestational Choriocarcinoma. | Int J Gynecol Cancer | 2018 |
| 27852036 | Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients. | Oncotarget | 2017 |
| 28251557 | Establishment and characterization of a platinum- and paclitaxel-resistant high grade serous ovarian carcinoma cell line. | Hum Cell | 2017 |
| 28456378 | High glucocorticoid receptor expression predicts short progression-free survival in ovarian cancer. | Gynecol Oncol | 2017 |
| 28650185 | Sexual misconduct in prison: What factors affect whether incarcerated women will report abuses committed by prison staff? | Law Hum Behav | 2017 |
| 28654152 | Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients. | Cancer | 2017 |